Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$473K Hold
9,826
0.15% 87
2016
Q3
$529K Hold
9,826
0.14% 82
2016
Q2
$533K Sell
9,826
-640
-6% -$33.7K 0.14% 83
2016
Q1
$530K Hold
10,466
0.14% 83
2015
Q4
$528K Hold
10,466
0.14% 83
2015
Q3
$503K Sell
10,466
-80
-0.8% -$4.16K 0.14% 90
2015
Q2
$549K Hold
10,546
0.16% 92
2015
Q1
$609K Hold
10,546
0.18% 92
2014
Q4
$564K Hold
10,546
0.19% 92
2014
Q3
$605K Hold
10,546
0.2% 91
2014
Q2
$705K Hold
10,546
0.23% 79
2014
Q1
$704K Hold
10,546
0.23% 76
2013
Q4
$703K Hold
10,546
0.23% 74
2013
Q3
$662K Buy
10,546
+120
+1% +$7.72K 0.23% 80
2013
Q2
$651K Buy
+10,426
New +$662K 0.22% 79

Other funds holding GSK

High Point Bank & Trust's GSK Position: Q4 2016 in Review

High Point Bank & Trust held its GSK (GSK) position steady in Q4 2016 at 9,826 shares worth $473K. The position accounts for 0.15% of the portfolio, ranked #87.

High Point Bank & Trust first reported a position in GSK in Q2 2013 and has held it in 15 quarters since. The position peaked at $705K in Q2 2014. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

  • High Point Bank & Trust held 9,826 shares of GSK worth $473K as of Q4 2016.
  • High Point Bank & Trust left its GSK share count unchanged in Q4 2016.
  • GSK made up 0.15% of High Point Bank & Trust's portfolio in Q4 2016, its #87 holding.
  • High Point Bank & Trust first reported a position in GSK in Q2 2013 and has held it in 15 quarters since.
  • High Point Bank & Trust's GSK position peaked at $705K in Q2 2014.
  • 762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on High Point Bank & Trust's 13F filing for Q4 2016, filed 28 Feb 2017.